SIGLEC1 and systemic lupus erythematosus: Another study performed by Zorn-Pauly et al. suggested that in newly diagnosed SLE patients, almost all patients had IFN-I pathway activation, and a negative flow cytometry result for CD169 is efficient for excluding SLE, whose negative predictive value is > 99% [113].